All the Active Ingredient Drugs
Biguanide, DPP-4 Inhibitor. Sitagliptin (as HCl monohydrate) 50 mg, Metformin Hydrochloride 1000 mg. FC Tabs.: 28/30/56/60/90. Dosage should be adj. indiv.
As an adjunct to diet and exercise to improve glyc. ctrol. in adlt. with type 2 diab. mell. Important limit. of use: should not be used in type 1 diab. or for diab. ketoacid., as it would not be effec. Has not been studied in pts. with a hist. of pancreatitis. It is unknown whether they are at incr. risk for the develop. of pancreat. while using this drug
C/I: Sev. renal impairm. (eGFR below 30 mL/min/1.73 m2)-
Diab. ketoacid.- Type 1 diab.- Hist. of serious hypersens. react. to this drug, sitagliptin, or metformin, such as anaphylaxis or angioedema.
Biguanide, DPP-4 Inhibitor. Sitagliptin (as HCl monohydrate) 50 mg, Metformin Hydrochloride 850 mg. FC Tabs.:14/28/30/90. Dosage should be adj. indiv.
As an adjunct to diet and exercise to improve glyc. ctrol. in adlt. with type 2 diab. mell. Important limit. of use: should not be used in type 1 diab. or for diab. ketoacid., as it would not be effec. Has not been studied in pts. with a hist. of pancreatitis. It is unknown whether they are at incr. risk for the develop. of pancreat. while using this drug
C/I: Sev. renal impairm. (eGFR below 30 mL/min/1.73 m2)-
Diab. ketoacid.- Type 1 diab.- Hist. of serious hypersens. react. to this drug, sitagliptin, or metformin, such as anaphylaxis or angioedema.